Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × Alemtuzumab × Clear all

NCT00935792 2017-09-26

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 1/2 Completed

28 enrolled 13 charts

Other hematologic neoplasm

Leukemia, Lymphoid, Hematologic Neoplasms

NCT00058825 2016-11-07

HIMSUM

Phase 1/2 Terminated

27 enrolled 13 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT00056966 2012-06-29

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Phase 1/2 Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma